Cite

HARVARD Citation

    Capodanno, D. et al. (2016). Reviewing the controversy surrounding pre-treatment with P2Y12 inhibitors in acute coronary syndrome patients. Expert review of cardiovascular therapy. pp. 811-820. [Online]. 
  
Back to record